Abstract
Background and Objective: Cutaneous leishmaniasis (CL) is the most common form of leishmaniasis affecting humans. The purpose of this study was to determine the prevalence and epidemiological features of CL in Iran by a systematic review and meta-analysis.
Methods: The literature search was performed in the SID, Magiran, IranDoc, PubMed, Scopus, Medlib, as well as the Google Scholar search engine databases to find studies on the prevalence of CL. The reference lists of the found articles were also reviewed to obtain additional relevant articles. Studies that were related to treatment and reservoirs of CL were excluded. Forty-four studies were selected for the final analysis.
Results: Meta-analysis with a random-effects model showed that the prevalence of leishmaniasis in Iran was 77 per 100,000 population. Overall, 60% of the patients were men. Most cases of CL occurred in autumn, and the majority of the patients had one lesion, mostly on hands. The most common age group was 20-30 years.
Conclusion: In conclusion, CL is an endemic disease in Iran, and its prevalence is largely affected by geographical locations and regional customs. Appropriate preventing measures should be considered to decrease the incidence of CL in Iran.
Keywords: Leishmaniasis, Iran, prevalence, systematic review, cutaneous, parasitic diseases.
[1]
Markle, W.H.; Makhoul, K. Cutaneous leishmaniasis: recognition and treatment. Am. Fam. Physician, 2004, 69(6), 1455-1460.
[PMID: 15053410]
[PMID: 15053410]
[2]
Kumar, R.; Ansari, N.A.; Avninder, S.; Ramesh, V.; Salotra, P. Cutaneous leishmaniasis in Nepal: Leishmania major as a cause. Trans. R. Soc. Trop. Med. Hyg., 2008, 102(2), 202-203.
[http://dx.doi.org/10.1016/j.trstmh.2007.10.017] [PMID: 18177679]
[http://dx.doi.org/10.1016/j.trstmh.2007.10.017] [PMID: 18177679]
[3]
Saghafipour, A.; Mostafavi, R. A Case Report of a Rare Leishmaniasis Patient with More than 29 Acute lesions. Qom Univ Med Sci J., 2011, 5(2), 87-89.
[4]
Control of the leishmaniases: report of a meeting of the WHO expert
committee on the control of leishmaniases; Organization,
W.H., Ed.; World Health Organization,. , 2010.
[5]
Rassi, Y.; Sofizadeh, A.; Abai, M.; Oshaghi, M.; Rafizadeh, S.; Mohebail, M. Molecular detection of Leishmania major in the vectors and reservoir hosts of cutaneous leishmaniasis in Kalaleh District, Golestan Province. Iran. J. Arthropod-Borne Dis., 2008, 2(2), 21-27.
[6]
Yaghoobi-Ershadi, M.R.; Javadian, E. Studies on sandflies in a hyperendemic area of zoonotic cutaneous leishmaniasis in Iran. Indian J. Med. Res., 1997, 105, 61-66.
[PMID: 9055497]
[PMID: 9055497]
[7]
Yaghoobi-Ershadi, M.R.; Jafari, R.; Hanafi-Bojd, A.A. A new epidemic focus of zoonotic cutaneous leishmaniasis in central Iran. Ann. Saudi Med., 2004, 24(2), 98-101.
[http://dx.doi.org/10.5144/0256-4947.2004.98] [PMID: 15323269]
[http://dx.doi.org/10.5144/0256-4947.2004.98] [PMID: 15323269]
[8]
Yaghoobi Ershadi, M; Akhavan, A; Zahraei Ramazani, A; Abai, M; Ebrahimi, B; Vafaei Nezhad, R Epidemiological study in a new focus of cutaneous leishmaniasis in the Islamic Republic of Iran. East Mediterr. Health J., 2004, 10(4-5), 688.
[9]
Mohebali, M.; Khamesipour, A.; Mobedi, I.; Zarei, Z.; Hashemi-Fesharki, R. Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran. Vaccine, 2004, 22(29-30), 4097-4100.
[http://dx.doi.org/10.1016/j.vaccine.2004.03.058] [PMID: 15364462]
[http://dx.doi.org/10.1016/j.vaccine.2004.03.058] [PMID: 15364462]
[10]
Bailey, M.S.; Lockwood, D.N.J. Cutaneous leishmaniasis. Clin. Dermatol., 2007, 25(2), 203-211.
[http://dx.doi.org/10.1016/j.clindermatol.2006.05.008] [PMID: 17350500]
[http://dx.doi.org/10.1016/j.clindermatol.2006.05.008] [PMID: 17350500]
[11]
Desjeux, P. Leishmaniasis. Public health aspects and control. Clin. Dermatol., 1996, 14(5), 417-423.
[http://dx.doi.org/10.1016/0738-081X(96)00057-0] [PMID: 8889319]
[http://dx.doi.org/10.1016/0738-081X(96)00057-0] [PMID: 8889319]
[12]
Ashford, R.W. Leishmaniasis reservoirs and their significance in control. Clin. Dermatol., 1996, 14(5), 523-532.
[http://dx.doi.org/10.1016/0738-081X(96)00041-7] [PMID: 8889331]
[http://dx.doi.org/10.1016/0738-081X(96)00041-7] [PMID: 8889331]
[13]
Desjeux, P. Leishmaniasis. Nat. Rev. Microbiol., 2004, 2(9), 692.
[http://dx.doi.org/10.1038/nrmicro981] [PMID: 15378809]
[http://dx.doi.org/10.1038/nrmicro981] [PMID: 15378809]
[14]
Tashakori, M.; Ajdary, S.; Kariminia, A.; Mahboudi, F.; Alimohammadian, M.H. Characterization of Leishmania species and L. major strains in different endemic areas of cutaneous leishmaniasis in Iran. Iran. Biomed. J., 2003, 7(2), 43-50.
[15]
Tashakori, M.; Kuhls, K.; Al-Jawabreh, A.; Mauricio, I.L.; Schönian, G.; Farajnia, S.; Alimohammadian, M.H. Leishmania major: genetic heterogeneity of Iranian isolates by single-strand conformation polymorphism and sequence analysis of ribosomal DNA internal transcribed spacer. Acta Trop., 2006, 98(1), 52-58.
[http://dx.doi.org/10.1016/j.actatropica.2006.01.010] [PMID: 16513079]
[http://dx.doi.org/10.1016/j.actatropica.2006.01.010] [PMID: 16513079]
[16]
Boer, den-M.; Argaw, D.; Jannin, J.; Alvar, J. Leishmaniasis impact and treatment access. Clin. Microbiol. Infect., 2011, 17(10), 1471-1477.
[http://dx.doi.org/10.1111/j.1469-0691.2011.03635.x] [PMID: 21933305]
[http://dx.doi.org/10.1111/j.1469-0691.2011.03635.x] [PMID: 21933305]
[17]
von Stebut, E.; Sunderkötter, C. Kutane Leishmaniasis. Hautarzt, 2007, 58(5), 445-458.
[http://dx.doi.org/10.1007/s00105-007-1327-8] [PMID: 17447043]
[http://dx.doi.org/10.1007/s00105-007-1327-8] [PMID: 17447043]
[18]
Röhrig, E.; Hamel, D.; Pfister, K. Retrospective evaluation of laboratory data on canine vector-borne infections from the years 2004-2008. Berl. Munch. Tierarztl. Wochenschr., 2011, 124(9-10), 411-418.
[PMID: 21950219]
[PMID: 21950219]
[19]
Kassiri, H.; Shojaei, S.; Kolahkaji, K. Epidemiological status of cutaneous leishmaniasis in Behbahan County, Khuzestan Province, SW Iran. Int. J. Infect. Dis., 2012, 16, e348.
[http://dx.doi.org/10.1016/j.ijid.2012.05.423]
[http://dx.doi.org/10.1016/j.ijid.2012.05.423]
[20]
Mohammadi Azni, S.; Nokandeh, Z.; Khorsandi, A. AR SD. Epidemiology of cutaneous leishmaniasis in Damghan district. J. Mil. Med., 2010, 12(3), 131-135.
[21]
Kassiri, H.; Lotfi, M.; Farajifard, P.; Kassiri, E. Laboratory diagnosis, clinical manifestations, epidemiological situation and public health importance of cutaneous leishmaniasis in Shushtar County, Southwestern Iran. J. Acute Dis., 2014, 3(2), 93-98.
[http://dx.doi.org/10.1016/S2221-6189(14)60024-X]
[http://dx.doi.org/10.1016/S2221-6189(14)60024-X]
[22]
Chegeni, SA; Amani, H; Kayedi, M; Yarahahmadi, A; Saki, M; Mehrdad, M Epidemiological survey of cutaneous leishmaniasis in Lorestan province (Iran) and introduction of disease transmission in new local areas. J. Ilam Uni. Med. Sci., 2011, 19(1), 54-60.
[23]
Saki, J.; Tavakoli, S.; Mardani, M.; Salmanzadeh, S.; Karamkhani, A. A 5-year period (2010–2014) retrospective study of human cutaneous leishmaniasis in Ahvaz County, southwest of Iran. Asian Pac. J. Trop. Dis., 2016, 6(6), 429-431.
[http://dx.doi.org/10.1016/S2222-1808(16)61061-7]
[http://dx.doi.org/10.1016/S2222-1808(16)61061-7]
[24]
Khademvatan, S.; Salmanzadeh, S.; Foroutan-Rad, M.; Bigdeli, S.; Hedayati-Rad, F.; Saki, J. Spatial distribution and epidemiological features of cutaneous leishmaniasis in southwest of Iran. Alexandria J. Med., 2017, 53(1), 93-98.
[http://dx.doi.org/10.1016/j.ajme.2016.03.001]
[http://dx.doi.org/10.1016/j.ajme.2016.03.001]
[25]
Dehghani, R.; Kassiri, H.; Mehrzad, N.; Ghasemi, N. The Prevalence, laboratory confirmation, clinical features and public health significance of cutaneous leishmaniasis in Badrood city, an old focus of Isfahan Province, Central Iran. 2014, 319-323.
[26]
Kassiri, H.; Feizhaddad, M-H.; Abdehpanah, M. Morbidity, surveillance and epidemiology of scorpion sting, cutaneous leishmaniasis and pediculosis capitis in Bandar-mahshahr County, Southwestern Iran. J. Acute Dis., 2014, 3(3), 194-200.
[http://dx.doi.org/10.1016/S2221-6189(14)60043-3]
[http://dx.doi.org/10.1016/S2221-6189(14)60043-3]
[27]
Hashemi, H.; Khodabakhshi, A.; Sepasian, M. An eco-epidemiological study of cutaneous leishmaniasis in Dezful, Iran, during 2004-2011. Journal of Occupational Health and Epidemiology., 2014, 3(1), 45-50.
[http://dx.doi.org/10.18869/acadpub.johe.3.1.45]
[http://dx.doi.org/10.18869/acadpub.johe.3.1.45]
[28]
Feizhadad, M.H.; Kassiri, H.; Kasiri, N.; Panahandeh, A.; Lotfi, M. Prevalence and epidemiologic profile of acute cutaneous leishmaniasis in an endemic focus. Southwestern Iran. J. Acute Dis., 2015, 4(4), 292-297.
[http://dx.doi.org/10.1016/j.joad.2015.06.007]
[http://dx.doi.org/10.1016/j.joad.2015.06.007]
[29]
Fatahibafghi, A; Eftekhari, M; Ahmadi, S; Moghateli, M. Epidemiological pattern of Cutaneous Leishmaniasis in the province of Fars, Iran (2010-2014).
[30]
Servat, F.L.; Soltani, T.; Derakhshan, Z.; Hosseini, A.S.; Nogyni, Z.A. A survey on epidemiology of leishmaniasis in Khatam, Iran during 2008-2012. Envir. Health Eng. Manag. J., 2016.
[http://dx.doi.org/10.15171/EHEM.2016.15]
[http://dx.doi.org/10.15171/EHEM.2016.15]
[31]
Firoozabadi, S.M.; Karami, K. Epidemiological study of cutaneous leishmaniasis in Ghir and Karzin County during 2009 to 2014. J. Prevent. Med., 2017, 3(4), 16-25.
[32]
Jayrvnd, A.A.; Vaziri, F. Epidemiology of cutaneous leishmaniasis in the city of Hawizeh in 2014-2015. J. Health. Field., 2017, 4(3)
[33]
Nourmoradi, H; Takhtfiroozeh, SM; Raeisi, N; Sagha, AA; Moghadam, FM; Moghadam, KF Epidemiological Study of Cutaneous Leishmaniasis during 2009 to 2014 in Kashan, Iran: A Potential Intra-domiciliary Transmission of the Disease. Journal of Advances in Medicine and Medical Research., 2016, 1-7.
[34]
Nazari, M.; Nazari, S.; Hanafi-Bojd, A.A.; Najafi, A.; Nazari, S. Situation analysis of cutaneous leishmaniasis in an endemic area, south of Iran. Asian Pac. J. Trop. Med., 2017, 10(1), 92-97.
[http://dx.doi.org/10.1016/j.apjtm.2016.12.001] [PMID: 28107873]
[http://dx.doi.org/10.1016/j.apjtm.2016.12.001] [PMID: 28107873]
[35]
Amraee, K.; Rastegar, H.A.; Beiranvand, E. An epidemiological study of cutaneous leishmaniasis in Poledokhtar district, Lorestan province, southwestern of Iran, 2001-2011. 2013.
[36]
Khajedaluee, M.; Yazdanpanah, M.J.; SeyedNozadi, S. Epidemiology of cutaneous leishmaniasis in population covered by Mashhad University of Medical Sciences in 2011. Med. J. Mash. Univ. Med. Sci., 2014, 57(4), 647-654.
[37]
Feiz Haddad, M.H.; Ghasemi, E.; Maraghi, S.; Tavala, M. Identification of Leishmania species isolated from human cutaneous leishmaniasis in Mehran, Western Iran using nested PCR. Iran. J. Parasitol., 2016, 11(1), 65-72.
[PMID: 27095970]
[PMID: 27095970]
[38]
Rajabzadeh, R.; Arzamani, K.; Shoraka, H.R.; Riyhani, H. Epidemiological survey and geographical distribution of cutaneous Leishmaniasis in North Khorasan province, 2006-2013. Int. J. Epid. Res., 2015, 2(4), 197-203.
[39]
Vazirianzadeh, B.; Hoseini, S.; Pour Rezaee, S.; Gardani, H.; Amraee, K. Prevalence of cutaneous leishmaniasis in Ramshir, Iran an epidemiological study. Int. Arch. Health Sci., 2014, 1(1), 41-37.
[40]
Feizhadad, M.H.F.; Safaei, K.; Saki, A.; Haddad, R.F. Epidemiological study of cutaneous leishmaniasis in southwest of Iran during 2001–2011. Asian Pac. J. Trop. Dis., 2016, 6(6), 432-436.
[http://dx.doi.org/10.1016/S2222-1808(16)61062-9]
[http://dx.doi.org/10.1016/S2222-1808(16)61062-9]
[41]
Nilforoushzadeh, M.A.; Bidabadi, L.S.; Hosseini, S.M.; Nobari, R.F.; Jaffary, F. Cutaneous Leishmaniasis in Isfahan Province, Iran, During 2001-2011. J. Skin Stem Cell., 2014, 1(2), e23303.
[http://dx.doi.org/10.17795/jssc23303]
[http://dx.doi.org/10.17795/jssc23303]
[42]
Nejati, J; Mojadam, M; Bojd, H; Ali, A; Keyhani, A; Habibi Nodeh, F. An epidemiological study of Cutaneous Leishmaniasis in Andimeshk (2005-2010). Sci. J .Ilam Univ. Med. Sci., 2014, 21(7), 94-101.
[43]
Roghani, A.R.; Yasemi, M.R.; Jalilian, M.; Abdi, J.; Rezai Tavirani, K. Epidemiology of cutaneous leishmaniasis in Ilam province. Resen. Med., 2013, 36(5), 50-53.
[44]
Hashemi, N; Hejazi, S; Hashemi, M. Epidemiology of Cutaneus Leishmaiasis in north khorasan in 2009-2011. J. North Khurasan Univ. Med. Sci., 2011, 3(3), 101-105.
[45]
Nazari, N.; Faraji, R.; Vejdani, M.; Mekaeili, A.; Hamzavi, Y. The prevalence of cutaneous leishmaniases in patients referred to Kermanshah hygienic centers. Zahedan J. Res. Med. Sci., 2012, 14(8), 77-79.
[46]
Youssefi, M.R.; Esfandiari, B.; Shojaei, J.; Jalahi, H.; Amoli, S.A.; Ghasemi, H. Prevalence of cutaneous leishmaniasis during 2010 in Mazandaran Province, Iran. Afr. J. Microbiol. Res., 2011, 5(31), 5790-5792.
[47]
Almasi, H.A. Epidemiological Study of Cutaneous Leishmaniasis in Marvdasht, Fars province, Iran. J. North Khorasan Uni. Med. Sci., 2012, 3(4), 15-23.
[48]
Barati, H.; Lotfi, M.H.; Mozaffari, G.A.; Barati, M.; Dehghan, H.R.; Firouze, A. Epidemiological aspects of cutaneous leishmaniasis in Yazd province within 2004–2013. J Comm. Health Res., 2016, 5, 131-139.
[49]
Kheirandish, F.; Sharafi, A.C.; Kazemi, B.; Bandehpour, M.;
Tarahi, Mj.; Khamesipour, A. First molecular identification of Leishmania species in a new endemic area of cutaneous leishmaniasis
in Lorestan, Iran. Asian Pac. J. Trop. Med., 2013, 6(9),
713-717..
[http://dx.doi.org/10.1016/S1995-7645(13)60124-8] [PMID: 23827149]
[http://dx.doi.org/10.1016/S1995-7645(13)60124-8] [PMID: 23827149]
[50]
Ramezani, Y.; Mousavi, S.G.A.; Bahrami, A.; Fereydooni, M.; Parsa, N.; Kazemi, B. Epidemiological study of cutaneous leishmaniasis in Aran and Bidgol from April to September 2009. KAUMS J., 2011, 15(3), 254-258.
[51]
Hamzavi, Y.; Sobhi, S.A.; Rezaei, M. Epidemiological factors of cutaneous lieshmaniasis in patients reffered to health centers in Kermanshah province (2001–2006). J. Kermanshah Univ. Med. Sci., 2009, 2(14), 151-161.
[52]
Zahirnia, A.; Moradi, A.; Nourouzi, N.; Bathei, S.; Erfani, H.; Moradi, A. Epidemiological survey of cutaneous Leishmaniasis in Hamadan province (2002-2007). J. Kermanshah Univ. Med. Sci., 2009, 2(14), 151-161.
[53]
Saghafipour, A. Epidemiology of Cutaneous Leishmaniasis in Qom Province, Iran, during 2003-2009. Qom Univ. Med. Sci. J., 2012, 6(1), 83-93.
[54]
Nazari, M. Cutaneous leishmaniasis in Hamadan, Iran (2004-2010). Zahedan J. Res. Med. Sci., 2012, 13(9), 39-42.
[55]
Moghateli, M.; Atesh, B.F.M.; Yoshany, N.; Movahed, E.; Jadgal, K.M.; Izadirad, H. Incidence rate of cutaneous leishmaniasis in Chabahar within 2008-2010. J. Comm. Health Res., 2016, 5(1), 29-35.
[56]
Lotfi, M.; Noori, S.; Firouze, A.; Fallahzadeh, H.; Ayatollahi, J. Epidemiological study an outbreak of cutaneous leishmaniasis in five endemic foci, Yazd province, March 2015-March 2016. J. Comm. Health Res., 2017, 6(2), 77-84.
[57]
Nikouee, F.; Soltanian, M.; Babaee, F.; Motamed-Jahromi, M. Cutaneous leishmaniasis: an epidemiological survey in Iran during 2013-2015. J Nurs Midwifery Sci., 2017, 4, 58-62.
[http://dx.doi.org/10.18869/acadpub.jnms.4.1.58]
[http://dx.doi.org/10.18869/acadpub.jnms.4.1.58]
[58]
Namrodi, J.; Soleymani, M.; Taheri, M.; Hosseini, S.S.; Moghateli, M. Epidemiological study of Cutaneous Leishmaniasis in Khash city from 2008 to 2014. Pajouhan Sci. J., 2016, 14(2), 1-7.
[59]
Kassiri, H.; Sabori, A.; Najafi, H.; Lotfi, M. Epidemiological features, clinical manifestation and laboratory findings of patients with cutaneous leishmaniasis in Genaveh County, Bushehr. J. Coast. Life Med., 2014, 2(12), 1002-1006.
[60]
Behbahani, A; Ahmadi, S; Latifi, M; Sadeghi, M Study of the frequency of Cutaneous Leishmaniasis in Omidieh district, Khouzestan province, south west of Iran (2008-2010). Jundishapur J. Health Sci., 2013, 4(4), 37-46.
[61]
Kassiri, H.; Sharifinia, N.; Jalilian, M.; Shemshad, K. Epidemiological aspects of cutaneous leishmaniasis in Ilam province, west of Iran (2000–2007). Asian Pac. J. Trop. Dis., 2012, 2, S382-S6.
[http://dx.doi.org/10.1016/S2222-1808(12)60186-8]
[http://dx.doi.org/10.1016/S2222-1808(12)60186-8]
[62]
Karami, M.; Doudi, M.; Setorki, M. Assessing epidemiology of cutaneous leishmaniasis in Isfahan, Iran. J. Vector Borne Dis., 2013, 50(1), 30-37.
[PMID: 23703437]
[PMID: 23703437]
[63]
Khosravani, M; Nasiri, Z; Keshavarz, D; Rafat-Panah, A Epidemiological trend of cutaneous leishmaniasis in two endemic focus of disease, south of Iran. J. Parasit. Dis., 2016, 40(4), 1609-1613.
[http://dx.doi.org/10.1007/s12639-015-0740-7]
[http://dx.doi.org/10.1007/s12639-015-0740-7]
[64]
Al-Tawfiq, J.A.; AbuKhamsin, A. Cutaneous leishmaniasis: a 46-year study of the epidemiology and clinical features in Saudi Arabia (1956-2002). Int. J. Infect. Dis., 2004, 8(4), 244-250.
[http://dx.doi.org/10.1016/j.ijid.2003.10.006] [PMID: 15234329]
[http://dx.doi.org/10.1016/j.ijid.2003.10.006] [PMID: 15234329]
[65]
Mujtaba, G.; Khalid, M. Cutaneous leishmaniasis in Multan, Pakistan. Int. J. Dermatol., 1998, 37(11), 843-845.
[http://dx.doi.org/10.1046/j.1365-4362.1998.00469.x] [PMID: 9865871]
[http://dx.doi.org/10.1046/j.1365-4362.1998.00469.x] [PMID: 9865871]
Related Journals
Current Medicinal Chemistry
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Endocrine, Metabolic & Immune Disorders - Drug Targets
Current HIV Research
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Current Probiotics
Related Books
Frontiers in Clinical Drug Research: Anti-Infectives
Frontiers in Anti-Infective Drug Discovery
Coronaviruses
Moving From COVID-19 Mathematical Models to Vaccine Design: Theory, Practice and Experiences
COVID-19: Effects in Comorbidities and Special Populations
An Update on SARS-CoV-2: Damage-response Framework, Potential Therapeutic Avenues and the Impact of Nanotechnology on COVID-19 Therapy
Mitochondrial DNA and the Immuno-inflammatory Response: New Frontiers to Control Specific Microbial Diseases
An Epidemiological Update on COVID -19
Frontiers in Clinical Drug Research – Anti Allergy Agents
Frontiers in Clinical Drug Research: Anti-Infectives
Article Metrics
14